Moderna CEO Stephane Bancel speaks with Bloomberg's Alix Steele and Guy Johnson on the company's covid vaccine trials, found to be 94% effective. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research for Bloomberg Intelligence, and Sarah Ponczek, Bloomberg cross-asset reporter, weigh in on the news. Tuna Amobi, Equity Research Analyst at CFRA Research, on outlook for the travel and hospitality industry. Hosted by Paul Sweeney and Vonnie Quinn. 

Moderna CEO Stephane Bancel speaks with Bloomberg's Alix Steele and Guy Johnson on the company's covid vaccine trials, found to be 94% effective. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research for Bloomberg Intelligence, and Sarah Ponczek, Bloomberg cross-asset reporter, weigh in on the news. Tuna Amobi, Equity Research Analyst at CFRA Research, on outlook for the travel and hospitality industry. Hosted by Paul Sweeney and Vonnie Quinn.

Listen for investment news and in-depth company research. 

Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: http://bit.ly/3vTiACF.

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Moderna CEO: 'Game-Changer' Vaccine Is Easier To Ship

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/1fd33554-abe9-49be-87dc-ae3c00371db7/transcript